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Dendritic cells (DCs) are essential antigen-presenting cells for the induction of T cell 
immunity against pathogens such as human immunodeficiency virus (HIV)-1. At the same 
time, HIV-1 replication is strongly enhanced in DC–T cell clusters, potentially undermining 
this process. We found that immature CD123
 
 
 
 plasmacytoid DCs (PDCs) and CD11c
 
 
 
 
myeloid DCs (MDCs) were susceptible to both a CCR5- and a CXCR4-using HIV-1 isolate in 
vitro and were able to efficiently transfer that infection to autologous CD4
 
 
 
 T cells. Soon 
after HIV-1 exposure, both PDCs and MDCs were able to transfer the virus to T cells in the 
absence of a productive infection. However, once a productive infection was established in 
the DCs, newly synthesized virus was predominantly spread to T cells. HIV-1 exposure of the 
MDCs and PDCs did not inhibit their ability to present cytomegalovirus (CMV) antigens and 
activate CMV-specific memory T cells. As a result, both PDCs and MDCs preferentially 
transmitted HIV-1 to the responding CMV antigen–specific CD4
 
 
 
 T cells rather than to 
nonresponding T cells. This suggests that the induction of antigen-specific T cell responses 
by DCs, a process crucial to immune defense, can lead to preferential HIV-1 infection and 
the deletion of responding CD4
 
 
 
 T cells.
 
HIV-1 infection is associated with a gradual
loss of CD4
 
 
 
 T cells and severe dysfunction of
the immune system. Of particular note, HIV-1
preferentially infects CD4
 
 
 
 T cells specific for
HIV-1 antigens, as compared with T cells with
other antigen specificities within infected indi-
viduals (1). Resting CD4
 
 
 
 T cells are the major
reservoir for HIV-1 infection in vivo (2–4).
DCs are important for stimulating antigen-
specific CD4
 
 
 
 T cell responses from the resting
memory T cell pool, as well as priming naive T
cells (5). Because DCs can be productively in-
fected with HIV-1, and infected DCs can be
found in mucosal tissues soon after viral trans-
mission (6, 7), they could potentially serve as
Trojan horses, delivering the signals necessary
for inducing CD4
 
 
 
 T cell responses while simul-
taneously delivering a lethal dose of HIV-1 to
those responding T cells. In fact, the DC–T
cell microenvironment has been described as
an “explosive” site for HIV-1 propagation, as
activated T cells become highly susceptible to
HIV-1 and thereby further enhance viral repli-
cation (8–12). Still, it is unknown whether
DCs are as central to the pathogenesis of HIV-1
infection as they are for generating effective,
adaptive anti–HIV-1 immunity.
Although studies of the role of DCs in
HIV-1 infection have substantially intensified
over the last decade, most knowledge has been
revealed using in vitro monocyte-derived DCs
to model this process, often using allogeneic T
cell lines as a surrogate for antigen-specific T
cells. To provide a more physiologic system,
we modeled the spread of HIV-1 during spe-
cific CMV antigen presentation by DC subsets
to autologous CMV-specific CD4
 
 
 
 T cells
isolated directly from blood. We investigated
CD123
 
 
 
 plasmacytoid DCs (PDCs) and
CD11c
 
 
 
 myeloid DCs (MDCs), both of which
have previously been found to be susceptible
to HIV-1 infection (13–16).
Here, these subsets of DCs were infected
with HIV-1 ex vivo and were subsequently
co-cultured with autologous CD4
 
 
 
 T cells.
Using flow cytometric analyses, we documented
that MDCs and PDCs displayed differential
susceptibility to the R5– and X4–HIV-1 strains
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BaL and IIIB, respectively, and both DC subsets were able to
preferentially transmit either virus strain to the antigen-spe-
cific T cells that were responding to the antigen expressed by
the DCs. Irrespective of the virus isolate, both PDCs and
MDCs were able to transfer the virus to T cells in the absence
of DC infection soon after HIV-1 exposure. However, once a
productive infection was established in the DCs, they pre-
dominately spread the newly synthesized virus to the respond-
ing T cells. The process of virus transfer to antigen-specific T
cells occurred predominantly within DC–T cell clusters.
 
RESULTS
Productive HIV-1 infection of MDCs and PDCs
 
Recently, we established a direct isolation procedure
whereby we purify relatively high numbers of human
CD123
 
 
 
 PDCs and CD11c
 
 
 
 MDCs from elutriated mono-
cytes (17). The overnight culture of freshly isolated DCs
leads to development of the characteristic DC morphology
and immature phenotype defined by low or moderate ex-
pression of the costimulatory molecules CD40, CD80,
CD86, and MHC class II (HLA-DR; reference 17). We
found that both DC subsets expressed CD4, CCR5, and
CXCR4, receptors used for HIV-1 infection (Fig. 1 A).
Prior studies have found HIV-1 RNA or DNA in both of
these DC subsets after HIV-1 exposure (13, 14, 16). We
found that high infection frequencies in DCs could be ob-
tained by exposing PDCs and MDCs to highly concentrated
and purified virus isolates for 72 h (16). Viral replication was
detected in MDCs and PDCs as early as 3 h after exposure
by the presence of viral negative strand DNA in the DCs,
and HIV-1 p24 antigen could be detected intracellularly af-
ter 24 h of exposure (16). No additional stimulation of the
DCs was required to induce viral replication. PDCs and
MDCs were shown to be susceptible to both CCR5-using
HIV-1
 
BaL
 
 and CXCR4-using HIV-1
 
IIIB
 
 (Fig. 1, B and C).
MDCs were significantly more susceptible to HIV-1
 
BaL
 
 than
to HIV-1
 
IIIB
 
, as shown by higher frequencies of p24
 
 
 
 cells in
donor-matched MDCs after HIV-1
 
BaL
 
 exposure (3.28 
 
 
 
0.62%; mean 
 
  
 
SEM) as compared with HIV-1
 
IIIB
 
 exposure
(0.68 
 
 
 
 0.30%; 
 
n 
 
  
 
14, P 
 
  
 
0.0005). The highest infection
rates overall were also found in HIV-1
 
BaL
 
–exposed MDCs.
This may be caused by the high expression of CCR5 on
MDCs (Fig. 1 A). There was no significant difference (
 
n 
 
 
 
14, P
 
  
 
0.24) in the infectability of PDCs to HIV-1
 
BaL
 
 (1.59 
 
 
 
0.39%) versus to HIV-1
 
IIIB
 
 (1.19 
 
 
 
 0.27%) despite high
CXCR4 expression (Fig. 1 A). No p24
 
 
 
 cells were present
in either of the DC cultures if the reverse transcriptase inhib-
itor azidothymidine (AZT) was added to the culture media
during the infection time, indicating that p24 expression
represented the production of new virus proteins within the
DCs (Fig. 1, B and C). At 72 h after HIV-1 exposure, the
cell viability was still comparable to the donor-matched un-
exposed DC cultures. In line with previous reports, we
found that only PDCs produced high amounts of IFN-
 
 
 
 in
response to HIV-1 exposure (Fig. 1 D; references 18, 19).
Both DC subsets differentiated partially in response to HIV-1
exposure alone, as found by up-regulation of CD40, CD80,
CD83, and CD86 (Fig. 1 E). However, Toll-like receptor
(TLR)7/8 ligation with R-848 led to complete maturation
exceeding the differentiation induced by HIV-1 exposure
alone (Fig. 1 E). We did not find that R-848–induced acti-
vation of HIV-1–exposed MDCs or PDCs led to a different
cell surface phenotype than the activation of uninfected
DCs (16).
 
HIV-1–infected DCs transfer the virus to autologous 
CD4
 
 
 
 T cells
 
Prior studies have shown that conjugates of DCs and T cells
are predominant sites for HIV-1 replication both in vivo and
in vitro (8–12). We examined the specific transfer of HIV-1
Figure 1. Productive HIV-1BaL and HIV-1IIIB infection in MDCs and 
PDCs. (A) Sorted CD11c  MDCs (red) and CD123  PDCs (blue) were ana-
lyzed for their expression of CD4, CCR5, and CXCR4 after overnight cul-
ture. MDCs (B) and PDCs (C) were exposed to HIV-1BaL or HIV-1IIIB in the 
presence or absence of AZT for 72 h using medium as a control. The level 
of HIV-1 infection was determined by intracellular p24 staining and flow 
cytometry. Any contaminating monocytes were excluded from the analysis 
by gating on the cells that expressed CD11c (MDCs) or CD123 (PDCs), but 
not CD14. The numbers in each gate represent the percentages of p24  
cells out of all cells. DCs from 2 of 14 representative donors are shown. 
(D) MDCs (black bars) and PDCs (white bars) from 12 individual donors 
(mean   SEM) were exposed to HIV-1BaL or HIV-1IIIB for 72 h and the 
supernatants were analyzed for IFN-  content by ELISA. Significant 
differences between the groups were assessed by Wilcoxon’s paired t test 
(***, P   0.0005). (E) Histograms of the cell surface expression of the 
costimulatory molecule CD86 on MDCs and PDCs are shown for one 
representative donor at 72 h (gray region, medium; black line, HIV-1BaL; 
green line, R-848 stimulation). 
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between HIV-1–exposed subsets of DCs and autologous
CD4
 
 
 
 T cells during antigen presentation. To establish such
an experimental system, we first evaluated the time required
for the transmission of HIV-1 from infected DCs to unin-
fected autologous T cells. MDCs or PDCs, isolated from
healthy CMV-seropositive donors, were exposed to HIV-1
for 72 h, washed thoroughly, and incubated briefly with inac-
tivated CMV antigen lysate or Staphylococcal enterotoxin B
(SEB), and then co-cultured with sorted CD4
 
 
 
 T cells la-
beled with carboxyfluorescein diacetate succinimidyl ester
(CFSE). The proliferation of CMV antigen-specific memory
T cells responding to DCs presenting processed CMV pep-
tides, or of T cells activated thorough TCR V
 
 
 
–restricted
SEB cross-linking between DCs and T cells, was assessed at
different time points after co-culture (1.5, 3.5, and 7.5 d) by
flow cytometry. To analyze only T cells, gates were set on
CFSE-labeled T cells excluding CD11c
 
 
 
 MDCs or CD123
 
 
 
PDCs. HIV-1 p24 expression and CFSE dilution in the T
cells were thereafter assessed and compared with T cells co-
cultured with uninfected DCs (Fig. 2). At 1.5 d after co-cul-
ture, there was no T cell division and no or very low intracel-
lular HIV-1 p24 in the T cells (Fig. 2 A). At 3.5 d, T cells
expressing HIV-1 p24 were detected and were more frequent
in cultures where T cell activation and division had been
stimulated (CMV or SEB) than in those where no stimula-
tion had occurred (Fig. 2 B). The frequency of p24
 
 
 
 T cells
increased over time. At 7.5 d after co-culture, a large per-
centage (ranging from 3 to 19%) of the T cells in the cultures
that had received CMV or SEB stimulation expressed p24,
whereas T cell infection in the nonstimulated cultures re-
mained minimal (Fig. 2 C). HIV-1–infected MDCs and
PDCs were able to activate CMV-specific T cells or SEB-
stimulated T cells to proliferate to a similar extent as unin-
fected donor-matched DCs (Fig. 2, C and D). Both HIV-
1
 
BaL
 
– and HIV-1
 
IIIB
 
–exposed MDCs or PDCs were able to
transfer the virus to CD4
 
 
 
 T cells as p24
 
 
 
 T cells were de-
tected after 3.5 d of co-culture, irrespective of which virus
isolate or DC subset was used. A time period of 3.5 d for cell
co-culture was therefore chosen for further studies. To en-
sure that virus saturation had not been reached in our culture
system, we exposed DCs to 10-fold dilutions of the virus
stocks before co-culture with T cells. Proportionally fewer T
cells became infected when co-cultured with DCs that had
been exposed to lower amounts of either HIV-1
 
BaL
 
 (Fig. 2 E)
or HIV-1
 
IIIB
 
 (unpublished data).
 
Differential transfer of HIV-1
 
BaL
 
 and HIV-1
 
IIIB
 
 from MDCs 
and PDCs to CD4
 
 
 
 T cells
 
As mentioned in Productive HIV-1...PDCs section, we
found that MDCs were more susceptible to R5-using HIV-
1
 
BaL
 
 than to X4-using HIV-1
 
IIIB
 
, whereas no preference was
found for PDCs (Fig. 1, B and C). We therefore asked how
efficiently the different virus strains were transferred from
the DC subsets to T cells during co-culture. MDCs were
shown to efficiently transfer both HIV-1
 
BaL
 
 and HIV-1
 
IIIB
 
 to
T cells (Fig. 3, A and E). We found no significant difference
in the efficiency of transfer and/or propagation of the differ-
ent virus isolates by the MDCs (P 
 
  
 
0.42; Fig. 3 E). In con-
trast, HIV-1
 
IIIB
 
 was more efficiently transferred to and prop-
agated in T cells by PDCs, as compared with HIV-1
 
BaL
 
 (P 
 
 
 
0.03; Fig. 3, B and E). Production of p24 in infected T cells
represents a late stage of the virus replication cycle and may
not reflect the absolute amount of virus that is transferred
from DCs to T cells (20). In addition, the infection of T cells
that appeared 3.5 d after co-culture may represent a direct
Figure 2. Transfer of HIV-1 from infected DCs to CD4  T cells. 
Sorted CD11c  MDCs were exposed to HIV-1BaL for 72 h, washed thoroughly, 
and incubated briefly with CMV or SEB before co-culture with sorted and 
CFSE-labeled autologous CD4  T cells. (A–C) Co-cultures were analyzed 
for T cell proliferation (CFSE dilution) and frequency of HIV-1 infection 
(intracellular p24 staining) after 1.5, 3.5, and 7.5 d. The numbers in each 
gate indicate the percentages of p24  cells out of all cells. (D) As a control, 
uninfected MDCs were co-cultured with T cells in the presence or absence 
of CMV or SEB to measure background staining for p24 and examine the 
rate of proliferation in the absence of HIV-1. The graphs show CD4  T 
cells gated on the presence of CFSE labeling, excluding single CD11c  cells 
to leave out MDCs from the analysis. One representative experiment of 
three is shown. The numbers in each gate indicate the percentages of 
p24  cells out of all cells. (E) PDCs (open squares) and MDCs (filled squares) 
were exposed to different doses of HIV-1BaL for 72 h before co-culture 
with T cells in the presence of SEB. The frequency of p24  T cells was 
again measured after 3.5 d of co-culture. One representative experiment 
of four is shown. 
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transfer of the virus from infected DCs, but may also repre-
sent T cell to T cell propagation of HIV-1 after an initial
transfer of the virus from DCs to T cells. To distinguish be-
tween these possibilities, we added the protease inhibitor In-
dinavir to the co-cultures (see Materials and methods). Indi-
navir allows the formation of p24 in infected cells, but blocks
the production of infectious viral particles and the subse-
quent spread of the virus between CD4
 
 
 
 T cells. The addi-
tion of Indinavir led to a reduction of p24
 
 
 
 T cells after co-
culture with HIV-1–infected DCs, indicating that HIV-1 is
primarily propagated by T cell to T cell spread after the ini-
tial transfer from DCs in this in vitro system (Fig. 3, A–D).
With Indinavir present in the co-culture, significantly higher
frequencies of p24
 
 
 
 T cells were found after co-culture with
HIV-1
 
BaL
 
– as compared with HIV-1
 
IIIB
 
–exposed MDCs (P 
 
 
 
0.02; Fig. 3, C and E). In contrast, HIV-1
 
IIIB
 
–exposed
PDCs were again able to infect a higher number of T cells as
compared with HIV-1
 
BaL
 
–exposed PDCs (P 
 
  
 
0.03; Fig. 3,
D and E). HIV-1
 
IIIB
 
 was transferred equally well by PDCs
and MDCs (P 
 
  
 
0.81). In contrast, HIV-1
 
BaL
 
 was more effi-
ciently transferred to T cells by MDCs than PDCs (P
 
  
 
0.008; Fig. 3, C–E). Although neither of the virus isolates
appeared to reach virus saturation at the inoculum concen-
tration (1 
 
 
 
g p24/ml) used for this comparison, it is still pos-
sible that different virus strains may have different transfer ef-
ficiencies from DC subsets to T cells at different virus titers.
Several factors may therefore influence the selection and
propagation of virus strains taking place in vivo.
 
Different pathways for transfer of the virus can be used by 
MDCs and PDCs
 
There are at least two pathways for the binding of HIV-1 by
DCs. In addition to the conventional CD4- and coreceptor-
mediated infection, HIV-1 can also bind to C-type lectin re-
ceptors such as DC-SIGN (CD209), which may lead to inter-
nalization by DCs (21–27). To examine whether a productive
infection by isolated PDCs and MDCs is required to transfer
the virus to T cells, we supplemented the culture media with
AZT during the 72 h of HIV-1 exposure of DCs. AZT was
thereafter washed out together with a residual virus before the
DCs were co-cultured with autologous CD4
 
 
 
 T cells for 3.5 d.
Co-culture of T cells with AZT-treated DCs resulted in no
p24 expression in the T cells (Fig. 4, A–D). This was true for
both PDCs and MDCs exposed to either HIV-1
 
BaL
 
 or HIV-
1
 
IIIB
 
 (Fig. 4, A–D). These data show that longer term HIV-1
transfer by PDCs and MDCs to T cells is dependent on the
productive infection of DCs. It has been shown that the time of
virus exposure influences the pathway for transfer of the virus
from DCs to T cells (27). To examine whether MDCs and
PDCs have the ability to transfer the early-captured virus in the
absence of infection, we limited the virus exposure time to 6 h,
washed, and then added T cells for 3.5 d. Both MDCs and
PDCs were able to pass the virus to T cells using this shorter vi-
rus exposure period (Fig. 4, E and F). Thus, in line with previ-
ous reports using other types of DCs, the MDCs and PDCs iso-
lated from blood also transfer HIV-1 to T cells in the absence of
a productive infection of the DCs soon after virus exposure.
DCs are predominantly of an immature phenotype when
they first encounter HIV-1 at peripheral sites, but are mainly
mature when they are located in lymph nodes to induce T
cell activation and, presumably, the transfer of HIV-1. There-
fore, to mimic the in vivo situation, immature MDCs and
PDCs were exposed to HIV-1 for 72 h and stimulated with
R-848 for the final 24 h to induce differentiation of DCs.
R-848 stimulation led to a phenotypic maturation of both
Figure 3. MDCs and PDCs transfer CCR5-using BaL and CXCR4-using 
IIIB with different efficiencies. Sorted CD11c  MDCs (A and C) and 
CD123  PDCs (B and D) were exposed to HIV-1BaL or HIV-1IIIB for 72 h, 
washed, and co-cultured with autologous CFSE-labeled CD4  T cells with 
SEB for 3.5 d in the absence (A and B) or presence (C and D) of the protease 
inhibitor Indinavir. Cultures were analyzed for T cell proliferation (CFSE 
dilution) and frequency of HIV-1 infection (intracellular p24 staining). The 
graphs show CD4  T cells gated on size and lack of CD11c or CD123 
expression to exclude DCs from the analysis. The numbers in each gate 
indicate the percentages of p24  cells out of all cells. One representative 
experiment of at least five is shown. (E) The graphs show the frequency of 
p24  T cells (mean   SEM) after co-culture with MDCs (black bars) or 
PDCs (white bars) exposed to the respective virus strains. The co-cultures 
were performed in the absence or presence of Indinavir, as indicated. 
Significant differences between the groups were assessed by Mann-Whitney’s 
unpaired t test (*, P   0.05).JEM VOL. 201, June 20, 2005 2027
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MDCs and PDCs (Fig. 1 E; reference 17). Maturation did not
lead to increased viral production in either MDCs or PDCs,
as measured by intracellular p24 expression (16). Despite this,
mature MDCs more efficiently transferred and/or induced
propagation of both HIV-1BaL and HIV-1IIIB in T cells than in
donor-matched immature MDCs (P   0.007 and P   0.03,
respectively; Fig. 4, A and B). There was no increase in the
viral transfer of either of the isolates after maturation of PDCs
(P   0.62 and P   0.84, respectively; Fig. 4, C and D). As for
immature DCs, viral transfer to T cells by mature DCs did not
occur when each of the DC subsets had been exposed to
AZT during the 72-h infection period (Fig. 4, A–D).
MDCs and PDCs preferentially transfer HIV-1 to antigen-
specific CD4  T cells
Viral transfer from DCs to T cells has been shown to occur
within an “infectious synapse” formed between a DC and an
adjacent CD4  T cell (27–30). Still, it is not known if T cells
become infected when DCs form a tight cluster with T cells
and the immunological synapses between the cells also serve
as infectious synapses. We have previously shown that HIV-
1–specific CD4  T cells are preferentially infected by HIV-1
in vivo (1). This would suggest that antigen-specific T cells
responding to a given antigen presented by an HIV-1–
infected DC would become infected more frequently than
T cells not responding to specific signals transmitted by the
DC. We investigated the relationship between a DC-medi-
ated HIV-1 infection and the specific activation of CD4  T
cells in more detail. Again, the HIV-1–infected DCs were
incubated with CMV antigens and then co-cultured with
autologous CD4  T cells. To ensure that HIV-1–infected T
cells were infected exclusively by the DCs and not indirectly
by T cell to T cell spread in the co-culture, the protease in-
hibitor Indinavir was added to the co-cultures. We initially
examined the frequency of p24  T cells or CD4  T cells
that did or did not produce the effector cytokines IFN- ,
TNF- , and/or IL-2 in response to CMV antigen presented
by the DCs (Fig. 5 A). In addition, as displayed by CFSE di-
lution, we gated on each cell division within the cytokine-
producing and noncytokine-producing T cells. We found
significantly higher frequencies of p24  T cells among the
cytokine-producing T cells as compared with the noncyto-
kine-producing T cells (P   0.0001). This indicates that
among the T cells present in the co-cultures, the CMV-spe-
cific T cells that were responding to CMV antigens pre-
sented by DCs were most likely to become HIV-1 infected.
The highest proportions of p24  cells were found in undi-
vided T cells or T cells that had divided only once. Because
induction of cytokine production occurs rapidly after mem-
ory T cell activation and before proliferation (31), this indi-
cates that a majority of the p24  T cells were recently both
activated and infected after their encounter with CMV anti-
gen–presenting and/or HIV-1–infected DCs. Productive in-
fection of T cells may lead to death before division and,
therefore, it is not surprising that the frequency of infected T
cells decreased in later divisions. In addition, HIV-1 Vpr
causes cell cycle arrest and may also explain why most of the
p24  T cells had not divided. Next, we examined whether
p24  or p24  T cells most often colocalized with the pro-
duction of effector cytokines (Fig. 5 B). Again, each cell di-
vision was analyzed. There was more than twice the fre-
quency of cytokine-producing CD4  T cells among the
p24  cells than p24  T cells. The greatest induction of pref-
erential infection of antigen-specific cells occurred in the
nondivided T cell population (Fig. 5, A and B). We also ex-
amined all the responding T cells in the co-cultures, i.e.,
both divided and cytokine-producing T cells (Fig. 5 C). Re-
sponding CMV-specific T cells were more frequently in-
fected than nonresponding T cells (P   0.0001; Fig. 5 C).
The HIV-1–infected p24  cells within the responding T
cells were more likely to express cytokines as compared with
the p24  T cells. The same pattern was observed when each
Figure 4. Pathways for transfer of virus from DCs to T cells differ 
with virus exposure time. Sorted CD11c  MDCs (A and B) and CD123  
PDCs (C and D) in the presence or absence of AZT were exposed to HIV-1BaL 
(A and C) or HIV-1IIIB (B and D) for 72 h with or without R-848 stimulation 
during the final 24 h. DCs were washed, pulsed with CMV or SEB, and 
co-cultured with autologous CD4  CFSE-labeled T cells for 3.5 d. The fre-
quency of p24  T cells after co-culture was analyzed by flow cytometry. 
The graphs show the percentage of p24  CD4  T cells gated on the 
presence of CFSE labeling and on size, excluding single CD11c /CD123  
DCs in 6–11 individual donors. The mean frequency of p24 expression is 
indicated in each column. Significant differences between the groups were 
assessed by Mann-Whitney’s unpaired t test (**, P   0.005; *, P    0.05). (E) 
MDCs (black bars) and PDCs (white bars) were exposed to HIV-1BaL for 
6 or 72 h in the absence or presence of AZT. DCs were then washed and 
co-cultured with T cells in the presence of SEB for 3.5 d. The graphs show 
the frequency of p24  T cells (mean   SEM) after co-culture in three donors.DCS TRANSFER HIV-1 TO ANTIGEN-SPECIFIC T CELLS | Loré et al. 2028
DC subset exposed to either HIV-1BaL or HIV-1IIIB was co-
cultured with T cells. This general trend—that HIV-1 infec-
tion was most frequent in responding T cells—was true both
in the presence of CMV or SEB using either immature or
mature DCs. This indicates that the majority of the infected
T cells had interacted with an HIV-1–infected DC that si-
multaneously presented antigen to which the TCR of the T
cells had specificity. Alternatively, the responding antigen-
specific T cells received an HIV-1 infection from HIV-1–
infected DCs that were in close proximity to the antigen-
presenting DCs.
To confirm our findings, we isolated fractions of re-
sponding and nonresponding T cells after co-culture with
infected DCs using flow cytometry. The different T cell
fractions (undivided cytokine producing; dividing [including
all divisions] cytokine producing; dividing noncytokine pro-
ducing; and undivided noncytokine producing) were ana-
lyzed for their content of HIV-1 gag DNA by real time
PCR (Fig. 6 A). Consistent with our p24 staining results, we
found that the largest amount of HIV-1 gag DNA was
present in the most recently activated T cells that had not
undergone cell division but produced cytokines (Fig. 6 A).
The second largest gag DNA content was found in dividing
and cytokine-producing T cells. The lowest gag DNA con-
tents were detected in undivided noncytokine-producing
cells, indicating that T cells that had not been activated by
DCs were less likely to become productively infected by
HIV-1. The same pattern was observed using each of the
DC subsets exposed to either HIV-1BaL or HIV-1IIIB (un-
published data).
The p24 stainings were performed at a time point suffi-
ciently distant from the initial interaction of DCs and T cells.
This allows for the possibility that the activation of T cells
and any subsequent infection may be temporally and mecha-
nistically distinct. To overcome this problem, we sorted re-
sponding and nonresponding T cells very soon (10 h) after
the initiation of co-culture with DCs. This provided a very
limited time for T cells to receive both activation signals and
HIV-1 infection from a DC. Cytokine-producing and non-
cytokine-producing T cells were sorted and HIV-1–negative
strand strong stop DNA (sssDNA), an early product of HIV-1
replication, was assessed by real time PCR (Fig. 6, B and
C). Delta count values demonstrating the number of cycles
required for the detection of HIV-1 sssDNA were used as an
estimate to examine the amount of early reverse transcripts
in the various fractions. On average, the responding cyto-
kine-producing T cells contained early reverse transcript lev-
els detectable at five fewer cycles of amplification as com-
pared with noncytokine-producing T cells. This difference
translates to  32-fold more early infection processes in re-
sponding as compared with nonresponding T cells. This in-
dicates that most infected T cells became activated and in-
fected at the same time, probably when they were still
engaged in an immunologic synapse.
HIV-1 is transferred in conjugates of infected DCs 
and T cells
We have previously shown that in co-cultures of HIV-1–
infected skin DCs (Langerhans cells) and T cells, the infected
p24  T cells predominantly appear in tight conjugates of T
cells and CD1a  Langerhans cells (32). We analyzed whether
this observation also held for MDCs and PDCs. We gated on
different cell populations within the co-cultures and exam-
ined them for p24 versus cytokine expression (Fig. 7, A and
B). Single MDCs or PDCs, expressing the DC-specific mark-
ers CD11c or CD123, respectively, but not associated with
CFSE-labeled T cells, were analyzed, as were undivided and
divided T cells not colocalized with DC markers. A separate
Figure 5. DCs mediate the spread of HIV-1 to antigen-specific 
CD4  T cells. Sorted CD11c  MDCs were exposed to HIV-1BaL for 72 h, 
washed thoroughly, and co-cultured for 3.5 d in the presence of CMV 
antigen and Indinavir with autologous CFSE-labeled CD4  T cells from a 
CMV-seropositive donor. The graphs show CD4  T cells gated on the presence 
of CFSE labeling and on size, excluding CD11c  MDCs. Each cell division 
was analyzed. IFN-  TNF-  IL-2 represents cytokine production. (A) Cyto-
kine-producing and noncytokine-producing T cells were analyzed for the 
frequency of HIV-1 infection by intracellular p24 staining (red, undivided 
cells; blue, first cell division; green, second cell division; orange, third cell 
division). Numbers represent the percentages of p24  cells out of all cells 
in that cell division. (B) HIV-1–infected p24  and p24  T cells were ana-
lyzed for their capacity to produce cytokines (red, undivided cells; blue, 
first cell division; green, second cell division; orange, third cell division). 
Numbers represent the percentages of cytokine-producing cells out of all 
cells in that cell division. (C) The total responding (i.e., cytokine-producing 
and/or divided) T cells were compared with respect to their frequency of 
HIV-1 infection. The p24 - and p24 -responding T cells were further ana-
lyzed for intracellular cytokine content. The numbers in each gate indicate 
the percentages of those cells out of all cells. The figure shows 1 represen-
tative experiment of 10.JEM VOL. 201, June 20, 2005 2029
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population of cells that coexpressed DC markers and CFSE
that represented cell conjugates was also analyzed. The pres-
ence or absence of DCs and T cells within these different cell
populations was confirmed by polychromatic flow cytometry
examining the expression of CD11c/CD123, CD3, CD4,
CD8, CD14, and CD20 (32, 33). Conjugate formation be-
tween DCs and T cells was observed among both undivided
and dividing T cells. Higher proportions of MDCs, as op-
posed to PDCs, were found in clusters with T cells (Fig. 7,
A–D). In addition, DC maturation led to a further increase in
cluster formation (unpublished data). Cell conjugates were
observed in all cultures whether unexposed or exposed to ei-
ther HIV-1BaL or HIV-1IIIB. The DC–T cell conjugates in
co-cultures with either PDCs or MDCs contained signifi-
cantly higher frequencies of infected p24  cells as compared
with undivided T cells not associated with DCs (n   10, P  
0.008). T cells that had undergone cell division, and thus
been activated by DCs at a prior time point, displayed similar,
but most often lower, frequencies of p24  T cells compared
with the T cells in the conjugates. The highest frequencies of
cytokine-producing cells were found in the population con-
sisting of cell conjugates as compared with the other three
populations (n   10, P   0.008). In addition, the proportion
of p24  cells that also produced cytokines was the highest in
the conjugates of DCs and T cells as compared with either
undivided or divided T cells (Fig. 7, A and B).
DISCUSSION
It is well documented that DCs can efficiently transfer HIV-1
to T cells. However, the exact nature of the T cells that re-
Figure 6. Responding T cells exhibit a higher viral replication. 
Sorted CD11c  MDCs and CD123  PDCs were exposed to HIV-1BaL or 
HIV-1IIIB for 72 h, washed thoroughly, and co-cultured in the presence of 
CMV antigen and Indinavir with autologous CFSE-labeled CD4  T cells 
from a CMV-seropositive donor. Fractions of responding and nonresponding 
T cells (undivided cytokine-producing; dividing [including all divisions] 
cytokine-producing; dividing noncytokine-producing; and undivided non-
cytokine-producing) were sorted using flow cytometry. (A) T cells sorted 
after 3.5 d of co-culture with HIV-1BaL–exposed MDCs were analyzed for 
their content of HIV-1 gag DNA copies per 105 T cells using quantitative 
real time PCR. The graph shows the mean   SEM of three donors. 
(B and C) T cells sorted after 10 h of co-culture with HIV-1–infected MDCs 
(B) or PDCs (C) were analyzed for their content of HIV-1 sssDNA (an early 
product of replication) using quantitative real time PCR. Delta count values 
demonstrate the numbers of cycles required for detection of HIV-1 sssDNA 
and were used as an estimate to examine replication activity in the various 
fractions. The graphs show the mean   SEM of two donors.
Figure 7. Conjugates of DCs and T cells are primary sites for viral 
production. Sorted CD11c  MDCs (A) or CD123  PDCs (B) were exposed 
to HIV-1BaL or HIV-1IIIB, respectively, for 72 h, washed thoroughly, and in-
cubated briefly with CMV before co-culture with CFSE-labeled autologous 
CD4  T cells for 3.5 d. The frequency of HIV-1 infection (p24) and cytokine 
production (IFN-  TNF-  IL-2) were analyzed in the following four popu-
lations: single CD11c /CD123  DCs, single undivided or divided T cells, 
and conjugates of DCs and T cells. The numbers in each quadrant indicated 
the percentage of total cells in that quadrant. The figure shows 1 repre-
sentative experiment of 10.DCS TRANSFER HIV-1 TO ANTIGEN-SPECIFIC T CELLS | Loré et al. 2030
ceive the infection is still unknown. We describe a novel co-
culture and flow cytometry model system to examine the
CD4  T cells that become infected by HIV-1 from blood-
derived subsets of DCs (MDCs and PDCs) during antigen
presentation. Our results suggest that DC-mediated HIV-1
infection of CD4  T cells does not occur randomly. In fact,
HIV-1 usurps the antigen presentation and activation func-
tions of DCs to specifically transfer HIV-1 to the T cells that
are responding to the antigens that these DCs are presenting.
This is possible because HIV-1 infection by itself does not
notably diminish the antigen-processing and T cell–activat-
ing properties of DCs. HIV-1 produced by DCs is therefore
provided an optimally activated CD4  T cell population in
which to establish a productive infection that can lead to the
depletion of the specific T cells that are responding to cog-
nate antigens. This would result in a specific loss of impor-
tant T cell specificities.
It has been suggested that HIV-1–infected DCs will
present infectious HIV-1 to HIV-1–specific CD4  T cells in
vivo (1). However, directly testing this in vitro is difficult
because it would require the use of DCs and T cells from
HIV-1–infected subjects, and few patients have adequate
numbers of HIV-1–specific CD4  T cells to carry out these
experiments (34, 35). Therefore, we used healthy CMV 
subjects with preserved CMV-specific CD4  T cells to
model the transfer of HIV-1 from infected DCs to antigen-
specific T cells. In our in vitro system, we showed that HIV-
1–infected MDCs and PDCs presenting CMV antigens both
activated preexisting autologous CMV-specific memory
CD4  T cells and preferentially transferred the virus to
them. This pattern was also seen when using SEB that in-
duced the cross-linking of TCRs as an alternative to using
CMV antigens to activate T cells. This mechanism of prefer-
ential transfer to antigen-specific T cells may explain why
HIV-1–specific T cells in infected individuals more fre-
quently contain HIV-1 than T cells with other TCR speci-
ficities (1). It should be noted that the mechanism of infec-
tion identified here is not the only route of infection of
CD4  T cells. We have previously shown that naive T cells
are infected in vivo (33), and this is unlikely to occur from
DCs according to antigen specificities. In addition, we show
here that once HIV-1 is transferred from a DC to an anti-
gen-specific T cell, that infection can rapidly spread from T
cell to T cell.
Immunological synapses are formed between DCs and T
cells during antigen presentation. MHC class II peptide–
bearing compartments within a DC have been shown to
move to the contact point between the DC and the interact-
ing TCR peptide–specific T cell (36, 37). HIV-1 may ex-
ploit this cellular machinery for transmission from infected
DCs to CD4  T cells. Viruses that spread from DCs to T
cells have been shown to be directed to the connection site
between the cells (28). DCs replicate HIV-1 poorly as com-
pared with activated CD4  T cells. Therefore, the efficient
transfer of a virus from DCs to T cells may require cell–cell
contact (38). We found that HIV-1 p24 was preferentially
detected in conjugates of DCs and T cells, suggesting that T
cells become activated and infected through cluster forma-
tion with infected DCs rather than from a free virus in the
culture media secreted by HIV-1–infected DCs. This is also
supported by the fact that we found early transcripts of HIV-1
primarily in CMV-specific cytokine-producing T cells, as
opposed to nonresponding T cells, only 10 h after co-culture
with infected DCs. Still, we have not demonstrated that it is
the HIV-1–infected DC that also presents CMV to, and ac-
tivates, CMV-specific T cells. Therefore, we cannot exclude
a scenario in which an uninfected DC presents CMV anti-
gens to a responding CMV-specific T cell that will receive
an HIV-1 infection from HIV-1–infected DCs that are in
close proximity.
Preferential transfer of the virus to antigen-specific T
cells occurred despite the differential susceptibility of DC
subsets to R5 (BaL)- and X4 (IIIB)-using virus isolates. We
have previously found that TLR7/8 ligation using R-848
led to differentiation of both MDCs and PDCs, which in
turn enabled them to activate higher frequencies of antigen-
specific T cells (17). We found that R-848–matured MDCs
transferred and propagated HIV-1 in T cells more efficiently
than immature MDCs. More conjugates were formed be-
tween MDCs and T cells when the MDCs were mature,
which would facilitate the milieu for viral transfer. Further-
more, the superior activation of T cells induced by mature
MDCs can lead to enhanced replication in T cells. There-
fore, although mature MDCs are better APCs and are essen-
tial for the induction of primary immune responses, they are
also better at transferring the virus. This ability of HIV-1 to
infect DCs and usurp their functions may accelerate the im-
mune depletion in an HIV-1 infection by specifically deplet-
ing responding CD4  T cells and allowing for an early
lacunar defect in the HIV-1–specific repertoire. We did not
see an increased transfer of the virus upon maturation of
PDCs. Although we have previously found that R-848–
matured PDCs are better APCs than immature PDCs (17),
they may not be superior at transferring the virus to T cells.
This may derive from the fact that exposure to either HIV-1
or R-848 will induce IFN-  production in PDCs (17–19),
which can prevent viral replication in T cells (39). In addi-
tion, PDCs are highly sensitive to long-term culture and
stimulation, and may die during the relatively long-term co-
culture used in our in vitro system.
Because of the low frequencies of DCs in vivo and the
difficulties in isolating these cells, several different sources for
DCs have been used to study the biology of DCs in the con-
text of HIV-1 infection. Numerous in vitro studies have
shown that there are at least two pathways by which HIV-1
interacts with DCs (21–27). These include the conventional
CD4- and coreceptor-mediated infection by HIV-1, as well
as the binding of the virus via DC-SIGN and other C-type
lectins. The mechanism of viral transfer from DCs to T cells
may first be dependent on the type of DC that is used.JEM VOL. 201, June 20, 2005 2031
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Monocyte-derived DCs have been shown to capture HIV-1
without infection and transmit the virus to T cells (23, 24,
27, 29). Viral transmission to T cells from isolated Langer-
hans cells has been shown to occur in a CD4-dependent
manner (22, 26, 40), but Langerhans cells can also bind
HIV-1 in a CD4-independent manner (25). The mechanism
of viral transfer may also be dependent on the time of viral
exposure (27). It has been shown that the initial phase of
HIV-1 transfer from monocyte-derived DCs to T cells is not
dependent on a productive infection. The virus captured
soon after DC exposure may thereafter be degraded and a
productive infection of DCs is then required for viral transfer
to T cells to occur at later time points (27). We found that
transmission of the virus to T cells by PDCs and MDCs re-
quired productive infection by the DCs after 72 h of virus
exposure, whereas soon after virus exposure (within 6 h),
DCs could pass the virus to T cells without being produc-
tively infected. Thus, despite phenotypic and functional dif-
ferences between MDCs, PDCs, and other DC types, they
may all use similar mechanisms to transfer HIV-1 to T cells.
It may be possible to prevent the spread of HIV-1 by
blocking conjugate formation between DCs and T cells, and
thereby decrease T cell activation and proliferation. On the
other hand, as the interaction between DCs and T cells is es-
sential for elicitation of primary and secondary immune re-
sponses against pathogens, inhibiting this general interaction
would not be without consequences. That said, a better un-
derstanding of the process by which HIV-1 targets antigen-
specific T cells and that leads to their productive infection
will certainly aid in our discovery of new and better ap-
proaches to vaccine and therapeutic agents.
MATERIALS AND METHODS
DC isolation. This study was approved by the National Institutes of
Health Institutional Review Board. Our sorting procedures for the direct
isolation of DC subsets from blood have been described previously (17). In
brief, PBMCs were collected from healthy, normal, CMV-seropositive
blood donors by automated leukapheresis. Enriched populations of lympho-
cytes and monocytes were obtained by counterflow centrifugal elutriation.
MDCs and PDCs were isolated from elutriated monocytes using magnetic
bead isolation, including DC isolation kits (Miltenyi Biotec), followed by
sequential separation (AutoMacs; Miltenyi Biotec). The BDCA-4 and the
CD1c isolation kits were used for the isolation of PDCs and MDCs, respec-
tively. After this purification, the DC subsets were highly enriched (on av-
erage,  75% of PDCs and  85% of MDCs) as determined by staining for
the lineage markers (CD3, CD14, CD15, CD20, and CD56), HLA-DR,
CD123, and CD11c, respectively. Any contaminating cells were mostly
monocytes. DCs were cultured in a complete medium of RPMI 1640 (Bio-
Whittaker, Inc.) supplemented with 2 mmol/liter L-glutamine, 1% strepto-
mycin and penicillin, and 10% FCS (Invitrogen). To maintain viability, the
media for PDCs and MDCs were supplemented with the recombinant hu-
man cytokines IL-3 (1 ng/ml; R&D Systems) and GM-CSF (2 ng/ml; Pep-
roTech), respectively.
HIV-1 virus growth and preparation. The CCR5-using HIV-1BaL iso-
late and the CXCR4-using HIV-1IIIB isolate (NIH AIDS Research and
Reference Reagent Program) were grown on PHA- (Sigma-Aldrich) and
IL-2– (Chiron Corp.) stimulated PBMCs. The p24Gag level in the cell cul-
ture supernatant was monitored by p24 ELISA and the viruses were har-
vested at a peak time point. To concentrate the virus and to minimize the
presence of bystander activation factors in the supernatant that could influ-
ence DC growth, the isolates were concentrated with an ultracentrifugation
machine at 30,000 rpm for 70 min at 4 C (Sorvall Surespin 630; Kendro).
The virus pellet was resuspended in fresh RPMI with 10% FCS to obtain a
5–10-fold concentrated clean virus stock.
Characterization of HIV-1 stocks. The viral titers of the HIV-1 stocks
were determined by p24 ELISA (PerkinElmer) according to the manufac-
turer’s instructions. The highly concentrated HIV-1BaL stock had 10  g/ml
HIV-1 p24Gag and the HIV-1IIIB stock had 5  g/ml HIV-1 p24. Virus tissue
culture ID50 was determined by a sensitive 14-d endpoint titration assay us-
ing PHA- and IL-2–stimulated PBMCs, as previously described (41). The
HIV-1BaL stock had 2.6   106 tissue culture ID50/ml and the HIV-1IIIB
stock 1.75   106 tissue culture ID50/ml.
HIV-1 infection and stimulation of DCs. The DC populations were
cultured at 106 cells/ml (with no less than 0.25   106 cells/tube) for 12 h at
37 C in polystyrene round-bottom tubes (Becton Dickinson). HIV-1BaL or
HIV-1IIIB (normalized by a final concentration of 1  g p24/ml, which
translated into a multiplicity of infection of 0.2–0.4) was thereafter added to
the DCs, and the cells were cultured for 6 or 72 h similar to as described
earlier (16, 42). For dose-response comparisons, the virus isolates were used
at 0.01–1  g p24/ml. In some experiments, 0.1  M AZT, a nucleoside an-
alogue that inhibits reverse transcription (Sigma-Aldrich), was added to the
cultures before addition of the virus isolate. To induce maturation, the DCs
were stimulated by the TLR7/8 ligand R-848 (1  g/ml, 4-amino-2-ethoxy-
methyl- ,  -dimethyl-1H-imidazoquinoline-1-ethanol; GLSynthesis Inc.)
as previously described (17). The DCs were exposed to HIV-1 for 72 h and
stimulated with R-848 during the final 24 h.
Phenotypic characterization and quantification of HIV-1 protein
in DCs. Cells were harvested, washed in PBS supplemented with 0.5%
BSA, and surface stained with different combinations of anti-CD11c,
-CD123, -CD3, -CD4, -CD14, -CD20, -CD40, -CD80, -CD83, -CD86,
and –HLA-DR antibodies (BD Biosciences). Cells were then washed, fixed,
and permeabilized using a 2  fixation–permeabilization solution (Becton
Dickinson). The frequency of HIV-1–infected DCs was determined by in-
tracellular staining for the HIV-1 gag protein p24 (anti-p24, clone KC57;
Beckman Coulter; references 16, 42). The DCs were also phenotyped using
anti–DC-SIGN (R&D Systems), anti-CCR5, and anti-CXCR4 (BD Bio-
sciences). Cell viability was evaluated by propidium iodide staining. The
cells were analyzed on a flow cytometer (FACSCalibur; Becton Dickinson).
Measurement of IFN-  release. The supernatants from HIV-1–
exposed and unexposed DCs were harvested and analyzed by ELISA (Bio-
source International) according to the manufacturer’s instructions (17).
Isolation and CFSE labeling of CD4  T cells. Enriched populations
of autologous negatively selected CD4  T cells, depleted of CD14 ,
CD15 , CD19 , CD56 , CD1c , BDCA-4 , and CD8  cells, were iso-
lated using microbeads (Miltenyi Biotec) on elutriated lymphocytes and se-
quential separation on AutoMacs. The purity was  96%. The sorted CD4 
T cells were frozen in 10% DMSO (Fisher Scientific) in FCS and stored at
 85 C until use. At the time of co-culture, the CD4  T cells were thawed
in the presence of 0.1 U/ml DNase I (RNase-free; Roche), washed thor-
oughly, and labeled with 0.25  M CFSE (Molecular Probes) as described
previously (31, 32). CFSE-labeled cells were washed and resuspended in
medium. Cell viability was determined by Trypan blue exclusion before co-
culture with DCs.
Co-culture of HIV-1–infected DCs with autologous CD4  T
cells. HIV-1–exposed or unexposed DCs were thoroughly washed by 3 
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fer of residual no–cell-associated virus. The DCs were pulsed with whole
CMV antigen lysate. The whole CMV antigen preparation (Microbix Bio-
systems) was derived from the CMV AD-169 virus strain grown in MRC-5
cells and inactivated by gamma irradiation. The CMV preparation was ti-
trated to find a dose that was not toxic to the cells yet adequate to activate
CMV specific memory T cells (10  L/ml). In some experiments, 0.2  g/ml
of the TCR superantigen SEB (Sigma-Aldrich) was used as an antigen instead
of CMV. The DCs were then co-cultured with sorted autologous CFSE-
labeled CD4  T cells in a DC/T cell ratio of 1:10 in complete media in
polystyrene round-bottom tubes. The DC–T cell co-cultures were carried
for 1–8 d with the addition of 1  g/ml Brefeldin A (Sigma-Aldrich) during
the last 12 h of co-culture. In some experiments, 1  M of the protease inhib-
itor Indinavir (Sigma-Aldrich) was added at initiation or 10 h of co-culture.
Analysis of a DC-mediated transfer of HIV-1 to antigen-specific T
cells. Co-cultures of DCs and T cells were harvested at the indicated time
points. Cells were surface stained with anti-CD11c Cy5-PE (for co-cultures
including MDCs) or anti-CD123 Cy5-PE (for co-cultures including
PDCs). Cells were then fixed and permeabilized in 2  fixation–permeabili-
zation solution (Becton Dickinson) for intracellular staining of HIV-1 p24
and cytokine expression using anti–p24 PE, anti–IFN-  APCs, anti–TNF- 
APCs (BD Biosciences), and anti–IL-2 APCs (Caltag Laboratories). The
cells were immediately analyzed on a FACSCalibur flow cytometer to pre-
vent leakage of CFSE dye from the cells. To stringently define the cell types
in the co-cultures, a phenotypic analysis was performed in detail with poly-
chromatic flow cytometry using anti-CD11c Cy5-PE/CD123 Cy5-PE,
CD3 Cy7-PE, CD4 Cy5.5-PE, CD8 Cy7-APC, CD14 Cy7-APC, and
CD20 Cy7-APC as previously described (32, 33). Stained cells were ana-
lyzed on a modified LSR II (Becton Dickinson). All data were evaluated by
FloJo software (Tree Star Inc.).
T cell sorting for the analysis of HIV-1 gag DNA content. DCs
were exposed to HIV-1BaL or HIV-1IIIB for 72 h and co-cultured with autolo-
gous CD4  T cells as described in Co-culture of...cells section. Co-cultures
were harvested at indicated time points and four different fractions of T cells
were then sorted on a FACSVantage SE/DiVa (Becton Dickinson). Cells were
gated on CD11c /CD123  CFSE-labeled T cells; subsequently, undivided
cytokine-producing, dividing cytokine-producing, undivided noncytokine-
producing, and dividing noncytokine-producing T cells were sorted. 15,000–
500,000 T cells in each fraction were collected and the pellets were frozen.
Viral DNA assessment. The HIV-1 strong stop DNA (an early event of
reverse transcription), full-length p17 gag DNA, and human albumin were
quantified by real-time PCR on an ABI7900HT (Applied Biosystems) as
previously described (1). In brief, the sorted cells were lysed in 0.1 mg/ml
proteinase K buffer in Tris-Cl (pH 8.0) at 100,000 cells per 10  l of buffer
by incubation at 56 C for 1 h and then at 95 C for 10 min. The lysate was
cleared by centrifugation at 14,000 g for 2 min. 5  l of the lysate was used in
a reaction volume of 25  l with 500 nM of primers (AA55, CTGCTA-
GAGATTTTCCACACTGACT; M667 , TAACTAGGGAACCCACT-
GCTTAA; gag FWD, GGTGCGAGAGCGTCAGTATTAAG; gag REV,
AGCTCCCTGCTTGCCCATA; Albumin Fwd, tgcatgagaaaacgccagtaa;
Albumin Rev, atggtcgcctgttcaccaa; Biosource International), 200 nM of
probes (strong stop DNA probe, FAM-AGAGTCACACAACAG-
ACGGGCACACACT-BHQ1; gag probe, FAM-AAAATTCGGTT-
AAGGCCAGGGGGAAAGAA-BHQ1; Albumin probe, FAM-tgacagagt-
caccaaatgctgcacagaa-BHQ1; Biosource International), 200 mM dNTPs, 3.5
mM MgCl2, and 1.25 mM Blue 636 reference dye with 0.625 U Platinum
Taq in the buffer supplied. The conditions were 95 C for 15 s and 60 C for
1 min for 50 cycles after a 2-min activation at 95 C. Quantitation was per-
formed by running standard curves for p17 gag and albumin controls.
Statistical analyses. Statistical analyses were performed using Wilcoxon’s
paired t test or Mann-Whitney’s unpaired t test with GraphPad Prism software.
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